Skip to main content
Clinical Trials/NCT01693497
NCT01693497
Completed
N/A

Comparison of a Gestalt-based Approach to PTSD Therapy With Cognitive Processing Therapy

Ludwig-Maximilians - University of Munich1 site in 1 country150 target enrollmentSeptember 2002

Overview

Phase
N/A
Intervention
Not specified
Conditions
Posttraumatic Stress Disorder
Sponsor
Ludwig-Maximilians - University of Munich
Enrollment
150
Locations
1
Primary Endpoint
PTBS Symptom Severity
Status
Completed
Last Updated
13 years ago

Overview

Brief Summary

This study aims to compare two active psychological treatments for PTSD. One is an established therapy, Cognitive Processing Therapy (CPT) which operates as a control condition for a newly developed intervention, an integrative Gestalt-based trauma therapy, Dialogical Exposure Therapy (DET). There is no inactive control condition. We expect the two therapies to perform on a similar level, which would constitute evidence for the efficacy of DET.

Registry
clinicaltrials.gov
Start Date
September 2002
End Date
April 2012
Last Updated
13 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Willi Butollo

Head of Clinical Psychology and Psychotherapy

Ludwig-Maximilians - University of Munich

Eligibility Criteria

Inclusion Criteria

  • main diagnosis of posttraumatic stress disorder
  • time since trauma is at least three months

Exclusion Criteria

  • acute suicidal ideation
  • severe personality pathology
  • substance dependence
  • early childhood trauma (e.g. child sexual abuse)
  • history of psychosis
  • dissociative identity disorder
  • neurological impairment (e.g. craniocerebral injury with functional impairment)
  • severe pre-traumatic depression
  • ongoing psychotherapy
  • lack of motivation

Outcomes

Primary Outcomes

PTBS Symptom Severity

Time Frame: change from pretreatment to posttreatment (planned duration 12 weeks on average) to follow-up (six months after posttreatment)

Even though participants are assessed by a clinical interview before entering the study, the primary outcome measure is the PDS which is applied before and after treatment as well as at 6-month follow-up.

Secondary Outcomes

  • PTSD Symptom change (IES-R)(change from pretreatment to posttreatment (planned duration 12 weeks on average) to follow-up (six months after posttreatment). Also measured at each session (up to 24 time points between pre- and posttreatment).)

Study Sites (1)

Loading locations...

Similar Trials